Alpha Tau to Join TASE Flagship TA-90 and TA-125 Indices in Early November
at www.tipranks.com (Thu, 29-Oct 12:47 PM)
DRTS highlights FDA clearance to expand REGAIN glioblastoma trial from 10 to 20 patients ahead of SNO 2026 data presentation
Market Chameleon (Mon, 19-Oct 9:11 AM)
Nadav Kidron’s Appointment to Nano Dimension’s Board Signals Strategic Shift for Alpha Tau Medical’s Governance
Market Chameleon (Mon, 17-Aug 8:31 AM)
